Kotak Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Kotak Mahindra Asset Management Co Ltd. The fund was launched on 11 December 2023 and is managed by Dhananjay Tikariha and Abhishek Bisen. As of 13 November 2026, the fund has an AUM of ₹860.74 Cr and its latest NAV is ₹17.97. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹100.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, J.B. Chemicals & Pharmaceuticals Ltd, Acutaas Chemicals Ltd, and Molbio Diagnostics Ltd. The fund has delivered 32.2% returns over the last 1 year and 22.2% annualised returns since inception.
Kotak Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






